Skip to main content

Drug–Nutrient Interactions in Patients Receiving Parenteral Nutrition

  • Chapter
  • First Online:
Handbook of Drug-Nutrient Interactions

Part of the book series: Nutrition and Health ((NH))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schneider PJ, Mirtallo JM. Medication profiles in TPN patients. Nutr Supp Serv 1983;3:40–46.

    Google Scholar 

  2. American Society for Parenteral and Enteral Nutrition Board of Directors and Standards Committee: Teitelbaum D, Guenter P, Howell WH, Kochevar ME, Roth J, Seidner DL. Definition of terms, style, and conventions used in A.S.P.E.N. guidelines and standards. Nutr Clin Pract 2005;20:281–285.

    Google Scholar 

  3. Food and Drug Administration. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm 1994; 51:1427–1428.

    Google Scholar 

  4. Isaacs JW, Millikan WJ, Stackhouse J, Hersch T, Rudman D. Parenteral nutrition of adults with 900-milliosmolar solution via peripheral vein. Am J Clin Nutr 1977;30:552–559.

    CAS  Google Scholar 

  5. Mirtallo JM. Parenteral formulas. In: Rombeau JL, Rolandelli RH, eds. Clinical nutrition: parenteral nutrition, 3rd ed. Philadelphia, PA: WB Saunders, 2001:118–137.

    Google Scholar 

  6. Task Force for the Revision of Safe Practices for Parenteral Nutrition and the A.S.P.E.N. Board of Directors. Safe practices for parenteral nutrition. JPEN J Parenter Enter Nutr 2004;28:S39–S70.

    Article  Google Scholar 

  7. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997;54:1295–1300.

    CAS  Google Scholar 

  8. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. J Parenter Enter Nutr 1999;23:67–74.

    Article  CAS  Google Scholar 

  9. Trissel LA. Handbook on injectable drugs. 15th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2009.

    Google Scholar 

  10. Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge: in vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterol 1990;99:1772–1778.

    CAS  Google Scholar 

  11. FDA Alert. Ceftriaxone (marketed as Rocephin) information, Sept 2007. Available from: http://www.fda.gov/cder/drug/infopage/ceftriaxone/default.htm, accessed 28 Feb 2008.

  12. FDA Alert. Information for healthcare providers: ceftriaxone (marketed as Rocephin and generics), April 2009. Available from: http://www.fda.gov/cder/drug/InfoSheets/HCP/ceftriaxone042009HCP.htm, accessed 22 April 2009.

  13. Belliard CR, Sibille G. Anaphylactoid shock or precipitation of calcium-ceftriaxone in a premature newborn: a case report (French). Arch Pediatr 2006;14:196–201.

    Google Scholar 

  14. Nehme AE. Nutritional support of the hospitalized patient. JAMA 1980;283:1906–1908.

    Article  Google Scholar 

  15. Wolfe RR, Durkot MJ, Allison JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism 1979;28:1031–1039.

    Article  CAS  Google Scholar 

  16. Rosemarin DK, Wardlaw GM, Mirtallo JM. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract 1996;11:151–156.

    Article  Google Scholar 

  17. Van den Berg G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367.

    Article  Google Scholar 

  18. McMahon MM, Rizza RA. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clinic Proc 1996;71:587–594.

    Article  CAS  Google Scholar 

  19. FDA. Parenteral Multivitamin Products; Drugs for Human Use; Amendment. Fed Reg 2000;65(77):21200–21201.

    Google Scholar 

  20. Zheng YJ, Tam YK, Coutts RT. Endotoxin and cytokine released during parenteral nutrition. JPEN 2004;28:163–168.

    CAS  Google Scholar 

  21. Knodell RG, Wood DG, Guengerich FP. Selective alteration of constitutive hepatic cytochrome P-450 enzymes in the rat during parenteral hyperalimentation. Biochem Pharmacol 1989;38:3341–3345.

    Article  CAS  Google Scholar 

  22. Yamaguchi M, Yamauchi A, Nishimura M, Ueda N, Naito S. Soybean oil fat emulsion prevents cytochrome P450 mRNA down-regulation induced by fat-free overdose total parenteral nutrition in infant rats. Biol Pharm Bull 2005;28:143–147.

    Article  CAS  Google Scholar 

  23. Raftogianis RB, Franklin MR, Galinsky RE. The depression of hepatic drug conjugation reactions in rats after lipid-free total parenteral nutrition administered via the portal vein. JPEN 1995;19:303–309.

    CAS  Google Scholar 

  24. Pantuck EJ, Pantuck CB, Weissman C, Gil KM, Askanazi J. Stimulation of oxidative drug metabolism by parenteral refeeding of nutritionally depleted patients. Gastroenterol 1985;89:241–245.

    CAS  Google Scholar 

  25. Burgess P, Hall RI, Bateman DN, Johnsto ID. The effect of total parenteral nutrition on hepatic drug oxidation. JPEN 1987;11:540–543.

    CAS  Google Scholar 

  26. Earl-Salotti GI, Charland SL. The effect of parenteral nutrition on hepatic cytochrome P-450. JPEN 1994;18:458–465.

    CAS  Google Scholar 

  27. Jorquera F, Culebras JM, González-Gallego J. Influence of nutrition on liver oxidative metabolism. Nutrition 1996;12:442–447.

    Article  CAS  Google Scholar 

  28. Shaw AA, Hall SD, Franklin MR, Galinsky RE. The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition. Drug Metab Dispos 2002;30:177–182.

    Article  CAS  Google Scholar 

  29. Cashman JR, Lattard V, Lin J. Effect of total parenteral nutrition and choline on hepatic flavin-containing and cytochrome P-450 monooxygenase activity in rats. Drug Metab Dispos 2004;32:222–229.

    Article  CAS  Google Scholar 

  30. Pai AB, Norenberg J, Boyd A, Raj D, Chan LN. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. Clin Ther 2007;29:2699–2705.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Mirtallo, J.M. (2009). Drug–Nutrient Interactions in Patients Receiving Parenteral Nutrition. In: Boullata, J., Armenti, V. (eds) Handbook of Drug-Nutrient Interactions. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-362-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-362-6_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-363-3

  • Online ISBN: 978-1-60327-362-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics